2 天
Study Finds on MSNWhen Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
8 小时
News-Medical.Net on MSNMediterranean diet shows promise in easing psoriasis, acne, and hidradenitis suppurativaHow the Mediterranean diet’s transformative power fights stubborn skin disorders—discover the science-backed strategies ...
Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
A systematic review revealed that patients with psoriasis have a significantly higher prevalence of onychomycosis than those without psoriasis.
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.
IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
13 天
MedPage Today on MSNInitiating Systemic Therapy for PsoriasisUntil about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...
Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...
In atopic dermatitis, psoriasis and other dermatologic diseases, T cells lose tolerance to self-antigens, triggering the autoimmune response that leads to abnormal skin cell proliferation and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果